Novel Adenosine Receptor Antagonists for Treating Cancer and Immune-Related Disorders.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel adenosine A2a receptor and adenosine A2b receptor inhibitors, pharmaceutical compositions, use of such compounds in treating cancer and immune-related disorders, and processes for preparing such compounds.